Dismay as X’s most-followed accounts given blue ticks for free

Elon Musk’s firm reverses policy of insisting on payment for ‘verified status’ – embarrassing some beneficiariesElon Musk has reversed one of his most notorious decisions since taking over X, the social network better known as Twitter, and started bestowing blue ticks on the site’s most followed users – whether they want them or not.The entrepreneur and one-time “Chief Twit” had tweeted last week that the service would grant free “premium” status to any user with more than 2,500 “verified subscriber follows” and accounts with more than 5,000 would get “premium+”. That policy is now being enacted. Continue reading...

Apr 4, 2024 - 21:30
 0  3
Dismay as X’s most-followed accounts given blue ticks for free

Elon Musk’s firm reverses policy of insisting on payment for ‘verified status’ – embarrassing some beneficiaries

Elon Musk has reversed one of his most notorious decisions since taking over X, the social network better known as Twitter, and started bestowing blue ticks on the site’s most followed users – whether they want them or not.

The entrepreneur and one-time “Chief Twit” had tweeted last week that the service would grant free “premium” status to any user with more than 2,500 “verified subscriber follows” and accounts with more than 5,000 would get “premium+”. That policy is now being enacted. Continue reading...

usnews US News is a reputable author that delivers a comprehensive range of up-to-date news to the United States and beyond. With a keen focus on providing the latest information across various fields, US News keeps readers informed about the most significant developments happening both domestically and globally. Whether it's politics, economics, technology, science, health, or culture, this author strives to cover diverse topics, ensuring a well-rounded news experience. By combining extensive research, journalistic integrity, and a commitment to accuracy, US News offers readers an invaluable resource to stay informed and make informed decisions in an ever-changing world.